StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “sell” rating on the stock.
Ayala Pharmaceuticals Price Performance
ADXS stock opened at $0.03 on Tuesday. The firm has a market capitalization of $1.28 million, a P/E ratio of 0.00 and a beta of 1.68. The business’s 50-day moving average is $0.03 and its two-hundred day moving average is $0.04. Ayala Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $0.78.
About Ayala Pharmaceuticals
Further Reading
- Five stocks we like better than Ayala Pharmaceuticals
- 3 Small Caps With Big Return Potential
- Can TikTok Stock Picks Really Make You Rich?
- How to trade using analyst ratings
- The “Quality” Rotation: Back to Basics Investing
- Why Invest in High-Yield Dividend Stocks?
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.